Menu
Currency
GWAS Study

Discovery, fine-mapping, and conditional analyses of genetic variants associated with C-reactive protein in multiethnic populations using the Metabochip in the Population Architecture using Genomics and Epidemiology (PAGE) study.

Kocarnik JM, Richard M, Graff M et al.

29878111 PubMed ID
GWAS Study Type
30503 Participants
31 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KJ
Kocarnik JM
RM
Richard M
GM
Graff M
HJ
Haessler J
BS
Bien S
CC
Carlson C
CC
Carty CL
RA
Reiner AP
AC
Avery CL
BC
Ballantyne CM
LA
LaCroix AZ
AT
Assimes TL
BM
Barbalic M
PN
Pankratz N
TW
Tang W
TR
Tao R
CD
Chen D
TG
Talavera GA
DM
Daviglus ML
CD
Chirinos-Medina DA
PR
Pereira R
NK
Nishimura K
BP
Bužková P
BL
Best LG
AJ
Ambite JL
CI
Cheng I
CD
Crawford DC
HL
Hindorff LA
FM
Fornage M
HG
Heiss G
NK
North KE
HC
Haiman CA
PU
Peters U
LM
Le Marchand L
KC
Kooperberg C
Chapter II

Abstract

Summary of the research findings

C-reactive protein (CRP) is a circulating biomarker indicative of systemic inflammation. We aimed to evaluate genetic associations with CRP levels among non-European-ancestry populations through discovery, fine-mapping and conditional analyses. A total of 30 503 non-European-ancestry participants from 6 studies participating in the Population Architecture using Genomics and Epidemiology study had serum high-sensitivity CRP measurements and ∼200 000 single nucleotide polymorphisms (SNPs) genotyped on the Metabochip. We evaluated the association between each SNP and log-transformed CRP levels using multivariate linear regression, with additive genetic models adjusted for age, sex, the first four principal components of genetic ancestry, and study-specific factors. Differential linkage disequilibrium patterns between race/ethnicity groups were used to fine-map regions associated with CRP levels. Conditional analyses evaluated for multiple independent signals within genetic regions. One hundred and sixty-three unique variants in 12 loci in overall or race/ethnicity-stratified Metabochip-wide scans reached a Bonferroni-corrected P-value <2.5E-7. Three loci have no (HACL1, OLFML2B) or only limited (PLA2G6) previous associations with CRP levels. Six loci had different top hits in race/ethnicity-specific versus overall analyses. Fine-mapping refined the signal in six loci, particularly in HNF1A. Conditional analyses provided evidence for secondary signals in LEPR, IL1RN and HNF1A, and for multiple independent signals in CRP and APOE. We identified novel variants and loci associated with CRP levels, generalized known CRP associations to a multiethnic study population, refined association signals at several loci and found evidence for multiple independent signals at several well-known loci. This study demonstrates the benefit of conducting inclusive genetic association studies in large multiethnic populations.

15,895 Hispanic individuals, 12,817 African American individuals, 1,252 Asian or Oceanian ancestry individuals, 539 Native American ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

30503
Total Participants
GWAS
Study Type
No
Replicated
Hispanic or Latin American, African American or Afro-Caribbean, Hispanic or Latin American, Native American, Asian unspecified, Oceanian
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.